HNC1058
/ Henovcom
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
March 21, 2024
A Study to Evaluate the Safety, Tolerability, PK and PD of HNC1058
(clinicaltrials.gov)
- P1 | N=32 | Completed | Sponsor: Guangzhou Henovcom Bioscience Co. Ltd. | Enrolling by invitation ➔ Completed
Trial completion • Idiopathic Pulmonary Fibrosis
January 03, 2024
A Study to Evaluate the Safety, Tolerability, PK and PD of HNC1058
(clinicaltrials.gov)
- P1 | N=32 | Enrolling by invitation | Sponsor: Guangzhou Henovcom Bioscience Co. Ltd. | Not yet recruiting ➔ Enrolling by invitation | Trial completion date: Sep 2023 ➔ Mar 2024 | Trial primary completion date: Aug 2023 ➔ Mar 2024
Enrollment open • Trial completion date • Trial primary completion date • Idiopathic Pulmonary Fibrosis
April 07, 2023
A Study to Evaluate the Safety, Tolerability, PK and PD of HNC1058
(clinicaltrials.gov)
- P1 | N=32 | Not yet recruiting | Sponsor: Guangzhou Henovcom Bioscience Co. Ltd.
New P1 trial
1 to 3
Of
3
Go to page
1